Imeglimin hydrochloride 98.0%~102.0% Frontida
The unique dual mechanism of action has potential to treat type 2 diabetes at all stages of the current treatment modality. It can be used as a monotherapy or as a supplement to other hypoglycemic therapies.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View